Aker BioMarine ASA (OSL:AKBM) Other Financing: kr-2 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:AKBM Aker BioMarine ASA OSL:AKBM
64 GF Score
Price kr109.00
GF Value kr74.55
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Aker BioMarine ASA Other Financing?

Aker BioMarine ASA OSL:AKBM -0.91% 64 Other Financing is kr-2 Mil as of Jun. 2026. GuruFocus rates OSL:AKBM with a GF Score™ of 64/100 and a GF Value™ of kr74.55 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Aker BioMarine ASA's Other Financing for the six months ended in Jun. 2026 was kr0 Mil.

Aker BioMarine ASA's Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 was kr-2 Mil.

Aker BioMarine ASA Other Financing Historical Data

* Premium members only.

The historical data trend for Aker BioMarine ASA's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aker BioMarine ASA Other Financing Chart

Aker BioMarine ASA Annual Data
Trend Dec11 Dec12 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.00 -1.01

Aker BioMarine ASA Semi-Annual Data
Dec10 Jun11 Dec11 Jun12 Dec12 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.06 -4,188.58 1.01 -2.02 0.00
OSL:AKBM
64GF Score
Aker BioMarine ASA OSL:AKBM
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aker BioMarine ASA Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of kr-2 Mil mean?
Aker BioMarine ASA (OSL:AKBM) has a Other Financing of kr-2 Mil as of Jun. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Aker BioMarine ASA and its competitors.
Is Aker BioMarine ASA's Other Financing too high?
Aker BioMarine ASA's current Other Financing is kr-2 Mil. Overall, Aker BioMarine ASA has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aker BioMarine ASA's Other Financing compare to KHC and GIS?
Aker BioMarine ASA's Other Financing of kr-2 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Consumer Packaged Goods company?
A good Other Financing depends on the Consumer Packaged Goods industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Aker BioMarine ASA and its competitors. Aker BioMarine ASA's current Other Financing is kr-2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aker BioMarine ASA stock overvalued right now?
Based on GuruFocus' analysis, Aker BioMarine ASA (OSL:AKBM) is currently considered Significantly Overvalued. The stock's GF Value™ is kr74.55, compared to a current price of kr109.00 — trading 46.2% above its estimated fair value. The current Other Financing is kr-2 Mil. Aker BioMarine ASA's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Aker BioMarine ASA (OSL:AKBM), the current Other Financing is kr-2 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aker BioMarine ASA (OSL:AKBM) Overvalued in 2026?

Based on GuruFocus' analysis, Aker BioMarine ASA stock appears to be overvalued. The current stock price of kr109.00 is trading 46.2% above its estimated GF Value™ of kr74.55. GuruFocus considers Aker BioMarine ASA to be Significantly Overvalued.

Key valuation signals for OSL:AKBM:

  • Other Financing: kr-2 Mil
  • GF Value™: kr74.55 vs. price of kr109.00 (46.2% above fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the OSL:AKBM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aker BioMarine ASA Business Description

Other Exchanges AKBMo:Sweden1PG:Germany
Address Oksenoyveien 10, Lysaker, NOR, 1366
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include Human Health Ingredients, Consumer Health Products, and Emerging Businesses. The company generates the majority of its revenue from the Human Health Ingredients segment, which includes Superba, Lysoveta, PL+ Algae, and the company's Houston manufacturing plant. The segment sells B2B krill oil supplements to nutritional brands for humans around the world.
64GF Score

Get the complete analysis for OSL:AKBM

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr109.00
Price
kr74.55
GF Value